Exercise or conversion by Adam Stone of 36300 shares of LianBio ADR subject to Rule 16b-3

LIANDelisted Stock  USD 2.18  0.05  2.24%   
About 61% of LianBio ADR's investor base is looking to short. The analysis of current outlook of investing in LianBio ADR suggests that many traders are alarmed regarding LianBio ADR's prospects. LianBio ADR's investing sentiment overview a quick insight into current market opportunities from investing in LianBio ADR. Many technical investors use LianBio ADR stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
  
Filed transaction by Lianbio director. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Read at macroaxis.com
LianBio insider trading alert for exercise of ordinary shares by Adam Stone, Interim CEO, on 26th of February 2024. This event was filed by Lianbio with SEC on 2024-02-20. Statement of changes in beneficial ownership - SEC Form 4

LianBio ADR Fundamental Analysis

We analyze LianBio ADR's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of LianBio ADR using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of LianBio ADR based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Beta

Beta Comparative Analysis

LianBio ADR is currently under evaluation in beta category among its peers. Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.

LianBio ADR Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with LianBio ADR stock to make a market-neutral strategy. Peer analysis of LianBio ADR could also be used in its relative valuation, which is a method of valuing LianBio ADR by comparing valuation metrics with similar companies.

Peers

LianBio ADR Related Equities

TILInstil Bio   2.52   
0%
50.0%
SNSESensei Biotherapeutics   2.33   
0%
46.0%
TERNTerns Pharmaceuticals   2.12   
0%
42.0%
INZYInozyme Pharma   1.68   
0%
33.0%
LRMRLarimar Therapeutics   0.98   
0%
19.0%
ASMBAssembly Biosciences   0.20   
0%
4.0%
ELDNEledon Pharmaceuticals   0.45   
9.0%
0%
DAWNDay One   0.47   
9.0%
0%
HOOKHookipa Pharma   0.47   
9.0%
0%
NUVBNuvation Bio   0.76   
15.0%
0%
NXTCNextCure   0.92   
18.0%
0%
FENCFennec Pharmaceuticals   0.98   
19.0%
0%
ABOSAcumen Pharmaceuticals   1.93   
38.0%
0%
ACHLAchilles Therapeutics   2.94   
58.0%
0%
VRCAVerrica Pharmaceuticals   5.00   
100.0%
0%
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.

Other Consideration for investing in LianBio Stock

If you are still planning to invest in LianBio ADR check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the LianBio ADR's history and understand the potential risks before investing.
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like